Supplemental Enteral Protein in Critical Illness

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-30

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is too determine the effect of enteral protein supplementation on biochemical measures of inflammation and protein metabolism in critically ill surgical patients. The investigators will also collect data on important clinical outcomes, including infectious complications, duration of mechanical ventilation and other measures of recovery from critical illness.

Hypothesis: That early supplemental protein will increase serum concentrations of transthyretin at three weeks after the onset of illness or injury. Secondarily, the investigators will test whether supplementation, reduces infectious complications and increases ventilator-free days.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Protein Consumption in Critically Ill Patients

NCT03048487

Critical Illness Dietary Modification

COMPLETED

Meeting Protein Targets in Critically Ill Patients

NCT03319836

Critical Illness Dietary Modification

COMPLETED

Early and Adequate Protein Feeding Post-Traumatic Injury

NCT02837861

Protein Feeding in Post-traumatic Injury Patients

COMPLETED EARLY_PHASE1

PRotEin Provision in Critical IllneSs

NCT04633421

Critical Illness Intensive Care Unit Acquired Weakness

COMPLETED NA

Replacing Protein Via Enteral Nutrition in Critically Ill Patients

NCT04475666

Critical Illness Nutrition Disorders

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Critically ill patients are frequently undernourished. The investigator's observations indicate that surgical and trauma patients who require artificial nutrition are likely to be markedly undernourished during the first week of critical illness, will often require intensive and costly support for organ failure, have prolonged stays in the intensive care unit and extended hospitalizations. Nitrogen deficits are typically greater and receive less attention than caloric deficits. In some respects, the focus on avoiding caloric deficits may have missed the mark. A broader consideration of nutrient needs, such as protein, is required. For instance, there are observational data supporting the notion that protein intake is at least as important as caloric intake in promoting recovery in critical illness. Only recently have national guidelines (ASPEN 2016) begun to specifically address protein requirements (1.5 - 2.0 g/kg/day). For a number of years, the approach to these critically ill patients has included weekly measurements of 24 hour urine nitrogen excretion in order to better understand the protein deficits that develop. Based upon physician preference, the investigators can then use enteral protein supplementation to match the urinary nitrogen excretion in order to achieve net "zero" nitrogen balance. With supplemental protein administration, physicians are able to reduce this deficit and in some cases, generate a positive nitrogen balance. However, there are no data to indicate that this approach (which is included as part of the 2016 ASPEN guidelines) improves clinical outcomes. The most obvious mechanism whereby supplemental protein may influence outcomes by providing more metabolic substrate for protein building. Feeding the gut likely creates a more anabolic environment and additional protein may facilitate anabolism. However, it is not known whether protein supplementation improves markers of anabolism and protein synthesis. In this study, the investigators will measure the anabolic effect of supplemental protein by following serum transthyretin concentrations as part of the standard clinical care.The investigators postulate that supplemental protein will attenuate the drop in comparison to no supplemental protein and will hasten the return to normal concentrations.

The proposed study will test whether early, and standardized protein supplementation: (1) Increases protein delivery during the first 2 weeks after injury, (2) increases serum transthyretin concentrations at 3 weeks after injury (3) increases ventilator-free days.

Study aims:

The aim of this study is to determine the effect of enteral protein supplementation on biochemical measures of protein metabolism in critically ill surgical patients. The investigators will also collect data on important clinical outcomes, including infectious complications, duration of mechanical ventilation and other measures of recovery from critical illness. However, this study will not enroll a sufficient number of subjects to adequately test for differences in these clinical end-points.

Hypothesis: That early supplemental protein will, increase serum concentrations of transthyretin at three weeks after injury. Secondarily, the investigators will test whether supplementation reduces infectious complications and increases ventilator-free days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nutrition Disorder Trauma Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

no protein supplementation

subjects receiving enteral nutrition without any protein supplementation

Group Type ACTIVE_COMPARATOR

Standard enteral nutrition

Intervention Type OTHER

Standard enteral nutrition.

protein supplementation

subjects receiving enteral nutrition with additional protein supplementation

Group Type EXPERIMENTAL

Protein supplementation

Intervention Type DIETARY_SUPPLEMENT

enteral protein supplementation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protein supplementation

enteral protein supplementation

Intervention Type DIETARY_SUPPLEMENT

Standard enteral nutrition

Standard enteral nutrition.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Critically ill adult trauma (blunt and penetrating) victims
* Other critically ill surgical patients
* enteral nutrition required during the first 96 hours after injury
* expected to require nutritional support for at least 1 week

Exclusion Criteria

* Significant chronic organ failure,
* severe malnutrition pre-existing prior to ICU admission
* not expected to survive from their traumatic injuries.
* intestinal discontinuity
* short bowel syndrome
* bowel obstruction
* enterocutaneous fistula
* intestinal ischemia
* massive gastrointestinal hemorrhage
* inability to obtain enteral access.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No